newsfilter
← Latest News
GlobeNewswire·

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update

–Four sites across the country participating in Phase 1b clinical trial for lead product candidate PH-762 –Three patients have been enrolled MARLBOROUGH, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals